Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat

Brain Research
Y ShirayamaK Takahashi

Abstract

We investigated the effects of chronic treatment with food containing one of five antidepressants on substance P (SP) content in the rat brain using radioimmunoassay and enzyme-immunoassay. The antidepressants used were imipramine, desipramine, clomipramine, amoxapine and mianserin. Following 40 days of treatment, all the antidepressants decreased SP concentrations in the striatum, substantia nigra and amygdala. Only imipramine and desipramine reduced the peptide content in the hippocampus, and only mianserin reduced it in the septum. We further examined the acute effects of antidepressants one hour after a single intraperitoneal administration. Acute imipramine and desipramine treatment reduced SP in the striatum, whereas acute mianserin decreased it in the striatum and substantia nigra. These results demonstrate that all antidepressants on chronic treatment had a common effect, a reduction of SP content in the striatum, substantia nigra and amygdala. This raises the possibility that such a decrease may contribute to the therapeutic action of antidepressants in affective disorders.

References

Oct 1, 1984·European Journal of Pharmacology·A OblinG Bartholini
Oct 1, 1984·European Journal of Pharmacology·P K SonsallaG R Hanson
Jul 1, 1980·The American Journal of Psychiatry·J C Ballenger, R M Post

❮ Previous
Next ❯

Citations

Aug 2, 2002·Neuroreport·Craig A StockmeierGrazyna Rajkowska
Apr 15, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Inga Herpfer, Klaus Lieb
Aug 16, 2008·The Mount Sinai Journal of Medicine, New York·Srijan Sen, Gerard Sanacora
Jul 31, 2013·PloS One·Andrew J MitchellAlan Saghatelian
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·S C StoutC B Nemeroff
Jul 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Alicia M Crissman, James M O'Donnell
Dec 11, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mark S KramerYih Lee
Apr 8, 2014·Amino Acids·Miguel Muñoz, Rafael Coveñas
Dec 4, 2013·Expert Opinion on Therapeutic Targets·Kanwaljit Chopra, Vipin Arora
May 20, 2003·The European Journal of Neuroscience·Laura CaberlottoRenzo Carletti
May 3, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Laura M HodgesSteven P Hamilton
May 1, 2012·TheScientificWorldJournal·Marisa RossoMichael Berger
Nov 17, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kashif HanifRituraj Konwar
Oct 3, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Alain GobertMark J Millan
May 13, 2015·Journal of Biosciences·Miguel MunozMaximino Redondo
Feb 18, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·B Bondy, P Zill
Nov 28, 2001·Journal of Neuroendocrinology·G Blackburn-Munro, R E Blackburn-Munro
Feb 19, 2005·Psychopharmacology·Valeriy SergeyevTomas Hökfelt
Jul 30, 2009·Expert Opinion on Emerging Drugs·Sidney H Kennedy, Sakina J Rizvi
Jul 6, 2006·Amino Acids·K Ebner, N Singewald
Feb 5, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiaoxu WangGuangzhong Zhang
Jul 20, 2020·Progress in Neuro-psychopharmacology & Biological Psychiatry·Qingzhong Wang, Yogesh Dwivedi
Oct 18, 2000·Journal of Psychosomatic Research·R Maunder
Feb 28, 2001·European Journal of Pharmacology·P W BurnetP J Harrison
Feb 26, 2003·European Journal of Pharmacology·Gonzalo A Carrasco, Louis D Van de Kar
Aug 21, 2003·Progress in Neurobiology·Mark J Millan
Feb 17, 2009·Seminars in Arthritis and Rheumatism·Don L Goldenberg
Sep 23, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Sakina J Rizvi, Sidney H Kennedy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.